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FIG. 1. Initial coronary angiography showed diffuse stenosis in the
proximal and mid portions of the LAD. LAD: left anterior descend-
ing artery.
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Although stent fracture after implantation of a drug-eluting stent (DES) is a rare com-
plication, it has been suggested to be a cause of restenosis. To date, most DES fractures 
have been associated with sirolimus-eluting stents. We describe here a case of a zotar-
olimus-eluting stent fracture after 8 months of stent placement in a calcified left ante-
rior descending artery lesion in a patient undergoing hemodialysis.
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INTRODUCTION
　Drug-eluting stents (DES) have greatly reduced in-stent 
restenosis by inhibiting neointimal growth. Recently, how-
ever, stent fracture has emerged as a complication associ-
ated with in-stent restenosis, stent thrombosis, and aneu-
rysm formation.
1,2 Most stent fractures are associated with 
sirolimus-eluting stent (SES) implantation in the right co-
ronary artery. Stent fractures are extremely rare with a pa-
clitaxel-eluting stent or zotarolimus-eluting stent (ZES) in 
the left anterior descending artery (LAD) or in a left circum-
flex artery lesion.
3
　Here we describe a case of a stent fracture that occurred 
with a ZES that had been implanted in a calcified LAD le-
sion in a patient undergoing hemodialysis due to chronic 
renal insufficiency.
CASE REPORT
　A 44-year-old male patient was admitted with a history 
of effort-related chest pain for several months. He had a his-
tory of diabetes mellitus for 8 years and chronic renal in-
sufficiency with hemodialysis for 3 years. The ECG showed 
left ventricular hypertrophy without ST segment change. 
　Coronary angiography revealed severe calcified eccen-
tric stenosis in the LAD (Fig. 1). The LAD was engaged with 
a 6-Fr guiding catheter (JL4, Cordis, Miami Lakes, FL, 
USA), predilatation was performed with a Sprinter 2.5×20 
mm balloon (Medtronic, Minneapolis, MN, USA), and a ZES 
(Endeavor 3.0×30 mm, Medtronic) was deployed at 12 atm. 
Additional high-pressure ballooning with a 3.0×12 mm bal-
loon (Quantum, Boston Scientific, Natick, MA, USA) at 16 
atm showed good angiographic results (Fig. 2). After the 
procedure, the patient remained asymptomatic, and he 
was discharged and followed up through the outpatient de-
partment. 58
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FIG. 2. Post-PCI angiography revealed well-deployed ZES. PCI:
percutaneous coronary intervention, ZES: zotarolimus-eluting
stent.
FIG. 3. Follow-up coronary angiography and fluoroscopy showed 
a gap in the stent strut. A-D: a gap in the stent strut.
FIG. 4. IVUS showed absent stent strut
at the fractured site. Serial IVUS fin-
dings at the fractured site. IVUS: intra-
vascular ultrasonography, white arrow:
fractured site.
　Eight months after the procedure, new recurrent chest 
pain developed during hemodialysis despite full anti-angi-
nal medication, and follow-up coronary angiography was 
performed. Mild in-stent restenosis was found in the mid-
dle of the previously implanted ZES, and fluoroscopic im-
ages showed that the ZES had a gap in the middle of the 
stent indicating a stent fracture (Fig. 3). Intravascular ul-
trasonography study (IVUS) with an automated pullback 59
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speed of 0.5 mm/s was performed, and the IVUS revealed 
partial absence of the stent struts in the middle of the stent, 
corresponding to the area of the stent fracture (Fig. 4). The 
external elastic lamina area was 4.82 mm
2, the stent area 
was 4.56 mm
2, the minimum lumen area was 4.21 mm
2, the 
neointimal area was 0.47 mm
2, and the percentage of neo-
intimal area was 28%.
　Although the minimal luminal area was over 4 mm
2 and 
the percentage of neointimal area was small, we decided 
on a stent-in stent strategy because of the patient’s re-
current chest pain after full anti-anginal medication and 
chose another kind of open cell designed stent. A paclitaxel- 
eluting stent (Taxus Liberte 3.0×12 mm, Boston Scientific) 
was deployed at the fractured site at nominal pressure. 
Final coronary angiography showed good results, and IVUS 
showed no discontinuation of the stent struts. 
　The patient was discharged with antiplatelet medication. 
No adverse cardiac events were noted during the 24 months 
of clinical follow-up, and the patient remains asymptomatic 
on medications.
DISCUSSION
　Stent fracture is rare but is considered to be an important 
cause for stent thrombosis, re-intervention, and myocardial 
infarction after DES implantation.
4,5 Increased mechan-
ical stresses on the stent predispose towards stent fracture. 
Factors such as a long, extremely angular and calcified le-
sion; post-dilatation with high pressure; and increased 
wall motion along the right coronary artery are likely to be 
contributing risk factors of stent fracture.
6,7 
　Sirolimus-eluting stent implantation is another in-
dependent predictor of stent fracture, and most cases have 
been reported with SES.
8,9 The closed cell design of the SES 
is less deformable in response to dynamic loading imposed 
by the movement of coronary arteries and makes a weak 
point at which a stent fracture may develop. However, stent 
fracture has also been reported with paclitaxel-eluting 
stents or ZES, although it is extremely rare,
10 and there 
have been no reported cases in the LAD in a hemodialyzed 
patient. 
　Revascularization of a stent fracture is controversial be-
cause there is a possibility of recurrence of the stent frac-
ture and the outcome of the stent fracture lesion is thought 
to be poor. In this case, we performed revascularization be-
cause the patient complained of angina and there was a risk 
of stent thrombosis or localized aneurysm formation.
11-14 
We successfully treated the patient with a different kind 
of open-cell-designed short stent implantation. We chose 
the SES because the closed-cell design tends to fracture by 
the movement of coronary arteries. Also, because we thou-
ght that the oversized, high-pressure ballooning may have 
contributed to stent fracture, we did not use high-pressure 
ballooning during the second percutaneous coronary inter-
vention, and the patient has remained asymptomatic du-
ring 9 months of clinical follow-up.
　Although stent fractures appear to be more frequent af-
ter SES implantation and in the right coronary artery, they 
can occur in any kind of DES and in any part of the coronary 
arteries, as in the present patient. Because clinical data on 
stent fractures are limited, future large multicenter stud-
ies will be required to determine the exact mechanisms and 
long-term management of stent fracture.
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